CLINICAL_TRIALS
trial_result
· 2016-04-22
Clinical Trial Update: Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer [Phase 2]
Summary
Phase II trial of tivozanib in advanced hepatocellular carcinoma was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Hepatocellular Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-04-22